Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Passchier EM"'
Autor:
Chan C; Center for Translational Immunology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Cabanes NC; Center for Translational Immunology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Jansen JHM; Center for Translational Immunology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Guillaume J; Center for Translational Immunology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Nederend M; Center for Translational Immunology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Passchier EM; Center for Translational Immunology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Gómez-Mellado VE; Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands., Peipp M; Division of Antibody-Based Immunotherapy, Department of Medicine II, Christian Albrechts University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, 24105, Kiel, Germany., Boes M; Center for Translational Immunology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.; Pediatrics Department, University Medical Center, Utrecht, The Netherlands., van Tetering G; Center for Translational Immunology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands., Leusen JHW; Center for Translational Immunology, University Medical Center, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands. J.H.W.Leusen@umcutrecht.nl.
Publikováno v:
Cancer immunology, immunotherapy : CII [Cancer Immunol Immunother] 2024 Oct 03; Vol. 73 (12), pp. 238. Date of Electronic Publication: 2024 Oct 03.
Autor:
Chan C; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Jansen JHM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Hendriks IST; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., van der Peet IC; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Verdonschot MEL; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Passchier EM; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Tsioumpekou M; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Nederend M; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Klomp SA; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Valerius T; Division of Stem Cell Transplantation and Immunotherapy, Department of Medicine II, Christian-Al-brechts University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany., Peipp M; Division of Antibody-Based Immunotherapy, Department of Medicine II, Christian Albrechts University Kiel and University Medical Center Schleswig-Holstein, Campus Kiel, Kiel, Germany., Leusen JHW; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands., Olofsen PA; Center for Translational Immunology, University Medical Center Utrecht, Utrecht, the Netherlands.
Publikováno v:
Molecular cancer therapeutics [Mol Cancer Ther] 2024 Sep 04; Vol. 23 (9), pp. 1317-1331.